Page Title Image

STRATEGIC VALUE, READY TO SCALE.


Partnership, licensing and integration opportunities around the Kinepict platform.

Why Kinepict

Proprietary Digital Variance Angiography technology, strong clinical relevance, and integration potential in angiography environments.


Clinical validation

The clinical value of KMIT is supported by peer-reviewed publications, conference presentations and real-world clinical use. Evidence generated across multiple angiography settings indicates relevance in image-quality improvement, dose management and workflow support. A structured package of key publications, case examples and product materials can be shared with qualified strategic partners under discussion.


Regulatory and product readiness

CE-marked and quality-system-backed development, with supporting documentation and product materials available upon request.


Contact for partnership discussions

For partnership, licensing, integration or strategic transaction discussions, please contact Kinepict directly. We welcome inquiries from imaging companies, device manufacturers, distributors with strategic scope, and potential acquirers. Introductory materials and follow-up documentation can be provided upon request.